Phenotypical features of a heterozygous form of familial hypercholesterolemia

被引:0
|
作者
Malyshev, P. P.
Rozhkova, T. A.
Solovyeva, E. Yu.
Meshkov, A. N.
Kaminnaya, V. I.
Kukharchuk, V. V.
机构
来源
TERAPEVTICHESKII ARKHIV | 2007年 / 79卷 / 09期
关键词
familial hypercholesterolemia; xanthomas; cholesterol;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To conduct a quantitative and qualitative analysis of phenotypical manifestations in patients with a heterozygous form of familial hypercholesterolemia (FHC) and to reveal factors involved in their development. Material and methods. A total of 247 patients with a clinical diagnosis of heterozygous FHC participated in the trial. Clinical manifestations of the disease in men and women were analysed and compared. Blood lipids were compared to those in the controls. A correlation analysis was used to reveal correlations between symptoms of the disease and lipid levels in the blood. Results. Tendon xanthomas were most frequent (79916) clinical sign with location primarily in Achilles' tendon. Incidence of basic clinical manifestations increased with age and significantly correlated with LDLP cholesterol. Two clinical signs were seen in 113 of the patients, three - in 13% (sex differences were insignificant). Mean levels of total cholesterol and LDLP serum cholesterol in heterozygous patients were 1.9 and 2.5 times higher than in the controls. Total cholesterol was significantly higher in women. A mean level of HDLP cholesterol was significantly lower while triglycerides were higher than in the control group. The disease symptoms manifested in men 5 years earlier than in women, FHC was diagnosed in men 7 5 years earlier. Conclusion. Patients with heterozygous FHC are characterized by higher levels of LDLP cholesterol, lower level of HDLP cholesterol and higher triglycerides in the serum than in healthy controls. Sex-related differences by severity and prevalence of basic symptoms in heterozygous FHC patients were not found. The time of clinical symptoms appearance and diagnosis evidences for more rapid progression of the disease in men.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [21] Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
    Singh, Aniruddha
    Mittal, Shilpi
    Kazimuddin, Mohammed
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 84 - 84
  • [22] Evolocumab in Children with Heterozygous Familial Hypercholesterolemia
    de Ferranti, Sarah D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1385 - 1386
  • [23] Treatment of children with heterozygous familial hypercholesterolemia
    Reiner, Zeljko
    Sahebkar, Amirhossein
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 304 : 177 - 178
  • [24] DIET IN CHILDREN HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA
    GLUECK, CJ
    TSANG, RC
    FALLAT, RW
    MELLIES, MJ
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1977, 131 (02): : 162 - 166
  • [25] Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Ruzza, Andrea
    Hovingh, G. Kees
    Wiegman, Albert
    Mach, Francois
    Kurtz, Christopher E.
    Hamer, Andrew
    Bridges, Ian
    Bartuli, Andrea
    Bergeron, Jean
    Szamosi, Tamas
    Santra, Saikat
    Stefanutti, Claudia
    Descamps, Olivier S.
    Greber-Platzer, Susanne
    Luirink, Ilse
    Kastelein, John J. P.
    Gaudet, Daniel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1317 - 1327
  • [26] Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
    Raal, Frederick J.
    Kallend, David
    Ray, Kausik K.
    Turner, Traci
    Koenig, Wolfgang
    Wright, R. Scott
    Wijngaard, Peter L. J.
    Curcio, Danielle
    Jaros, Mark J.
    Leiter, Lawrence A.
    Kastelein, John J. P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1520 - 1530
  • [27] PROCEDURE FOR THE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Benedi, Victoria Marco
    Gasso, Salvador Olmos
    Lagunas, Ana Cenarro
    Corredoira, Pablo Fernandez
    Sanz, Ana M. Bea
    Murillo, Fernando Civeira
    [J]. ATHEROSCLEROSIS, 2024, 395
  • [28] PHENOTYPICAL AND MOLECULAR CHARACTERIZATION OF FAMILIAL HETEROZYGOUS HYPOBETALIPOPROTEINEMIA (FHBL)
    Di Filippo, M.
    Chebel-Dumont, S.
    Peretti, N.
    Samson-Bouma, M. E.
    Benlian, P.
    Rabes, J. P.
    Carrie, A.
    Lapoirie, M.
    Nouvel, M.
    Lachaux, A.
    Moulin, P.
    Sassolas, A.
    [J]. ATHEROSCLEROSIS, 2014, 235 (02) : E97 - E97
  • [29] Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Wiegman, Albert
    Caprio, Sonia
    Cariou, Bertrand
    Averna, Maurizio
    Poulouin, Yann
    Scemama, Michel
    Manvelian, Garen
    Garon, Genevieve
    Daniels, Stephen
    [J]. JAMA PEDIATRICS, 2024, 178 (03) : 283 - 293
  • [30] DIFFERENT PHENOTYPES IN SIBLINGS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kyselak, O.
    Soska, V.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E182 - E182